We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Wireless Connectivity Transforms POC Blood Glucose Testing

By LabMedica International staff writers
Posted on 07 Jul 2011
The National Health Service (NHS; United Kingdom) Trust has installed wireless blood glucose meters in wards, clinics, and theaters across all three of its acute hospital sites in Mid Yorkshire (United Kingdom).

Wireless devices, connected by intelligent IT systems are vital for patient safety and for meeting Clinical Pathology Accreditation (CPA) requirements for Point of Care (POC) testing.

The meters are linked wirelessly to the Hospital Information System (HIS) via the Roche POC data management solution, cobas IT 1000, allowing them to be managed centrally in accordance with national guidelines for POC devices.

In addition to transmitting patient results, Roche Diagnostic's (Burgess Hill, United Kingdom) blood glucose meter, Accu-Chek Inform II records quality control (QC) results, operator and patient details, consumable details, configuration information, and comments. More...
The data transmitted by the meters is managed by cobas IT 1000, which permits patient validation, operator recognition, and material lot tracking.

“Our new blood glucose testing system helps us to fulfill CPA requirements in a number of ways,” explained Tracey Eastwood, senior BMS responsible for POC testing within the Trust. “It provides a central record of all data, including QC records, which, in turn, provide an important audit trail. The system also enables us to manage reagents, calibrations, and quality control centrally. Centralized calibration of glucose meters has removed the risk of operator errors and the QC lockout feature ensures that operators perform the necessary QC activities at the required intervals, otherwise the meter cannot be used.”

While there is no cure for diabetes at the moment, management of the disease has become more effective.

Related Links:

National Health Service
Roche Diagnostics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Slide Scanner System
NanoZoomer S540MD
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Biodesix is developing a radiomics-based lung nodule risk assessment test to complement its Nodify Lung portfolio (Photo courtesy of Biodesix)

Multimodal Platform to Combine Blood and Imaging Biomarkers for Lung Nodule Assessment

Lung nodules are commonly detected during chest imaging and require careful risk assessment to determine whether follow-up imaging, additional testing, or biopsy is needed. With millions of patients evaluated... Read more

Molecular Diagnostics

view channel
Image

GeneDx Presents Evidence for Wider Clinical Use of Genomic Sequencing at ASHG 2026

GeneDx (Gaithersburg, MD, USA) is presenting 27 scientific abstracts at the American Society of Human Genetics (ASHG) 2026 Annual Meeting, taking place October 20–24 in Montreal, Canada.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.